The emerging role of epigenetics in cardiovascular disease

Therapeutic Advances in Chronic Disease

Volumn 5, Issue 4, 2014, Pages 178-187

  Abi Khalil, Charbel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Cardiac hypertrophy; Cardiology; Cardiovascular disease; Coronary artery disease; Diabetes; Epigenetics; Heart failure

Indexed keywords

BLOOD CLOTTING FACTOR 7; CD31 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 133A; MICRORNA 155; MICRORNA 17 92; MICRORNA 181; MICRORNA 195; MICRORNA 212; MICRORNA 214; MICRORNA 23A; MICRORNA 23B; MICRORNA 24; MONOCARBOXYLATE TRANSPORTER 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CARDIOVASCULAR DISEASE; CHEMICAL MODIFICATION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HISTONE MODIFICATION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

EID: 84902208555     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622314529325     Document Type: Review

References (110)

1. Abbott A. (2010) Project set to map marks on genome. Nature 463: 596–597.
2. Abi Khalil C. Roussel R. Mohammedi K. Danchin N. Marre M. (2012) Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol 19: 374–381.
3. Antos C. McKinsey T. Dreitz M. Hollingsworth L. Zhang C. Schreiber K. et al. (2003) Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278: 28930–28937.
4. Baccarelli A. Wright R. Bollati V. Litonjua A. Zanobetti A. Tarantini L. et al. (2010) Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 21: 819–828.
5. Barrick C. Roberts R. Rojas M. Rajamannan N. Suitt C. O'Brien K. et al. (2009) Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice. Am J Physiol Heart Circ Physiol 297: H65–H75.
6. Berger S. (2007) The complex language of chromatin regulation during transcription. Nature 447: 407–412.
7. Bierne H. Hamon M. Cossart P. (2012) Epigenetics and bacterial infections. Cold Spring Harbor Perspect Med 2: a010272.
8. Bingham A. Ooi L. Kozera L. White E. Wood I. (2007) The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes. Mol Cell Biol 27: 4082–4092.
9. Bird A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6–21.
10. Bird A. (2007) Perceptions of epigenetics. Nature 447: 396–398.
11. Bokil N. Baisden J. Radford D. Summers K. (2010) Molecular genetics of long QT syndrome. Mol Genet Metab 101: 1–8.
12. Breitling L. Salzmann K. Rothenbacher D. Burwinkel B. Brenner H. (2012) Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J 33: 2841–2848.
13. Breitling L. Yang R. Korn B. Burwinkel B. Brenner H. (2011) Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 88: 450–457.
14. Buro-Auriemma L. Salit J. Hackett N. Walters M. Strulovici-Barel Y. Staudt M. et al. (2013) Cigarette smoking induces small airway epithelial epigenetic changes with corresponding modulation of gene expression. Hum Mol Genet 22: 4726–4738.
15. Carè A. Catalucci D. Felicetti F. Bonci D. Addario A. Gallo P. et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613–618.
16. Castro R. Rivera I. Struys E. Jansen E. Ravasco P. Camilo M. et al. (2003) Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49: 1292–1296.
17. Chen K. Wang Y. Hu C. Chang W. Liao Y. Dai C. et al. (2011) OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 25: 1718–1728.
18. Chen T. Huang Z. Wang L. Wang Y. Wu F. Meng S. et al. (2009) MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP 9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 83: 131–139.
19. Dang M. Buzzetti R. Pozzilli P. (2013) Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev 29: 8–18.
20. Egger G. Liang G. Aparicio A. Jones P. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457–463.
21. El-Osta A. (2012) Glycemic memory. Curr Opin Lipidol 23: 24–29.
22. El-Osta A. Brasacchio D. Yao D. Pocai A. Jones P. Roeder R. et al. (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205: 2409–2417.
23. Esteller M. (2008) Epigenetics in cancer. N Engl J Med 358: 1148–1159.
24. Fang Y. Shi C. Manduchi E. Civelek M. Davies P. (2010) MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 107: 13450–13455.
25. Feinberg A. (2010) Epigenomics reveals a functional genome anatomy and a new approach to common disease. Nat Biotechnol 28: 1049–1052.
26. Fouse S. Nagarajan R. Costello J. (2010) Genome-scale DNA methylation analysis. Epigenomics 2: 105–117.
27. Friedman R. Farh K. Burge C. Bartel D. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92–105.
28. Friso S. Lotto V. Choi S. Girelli D. Pinotti M. Guarini P. et al. (2012) Promoter methylation in coagulation F 7 gene influences plasma FVII concentrations and relates to coronary artery disease. J Med Genet 49: 192–199.
29. Fuke C. Shimabukuro M. Petronis A. Sugimoto J. Oda T. Miura K. et al. (2004) Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 68: 196–204.
30. Gal-Yam E. Saito Y. Egger G. Jones P. (2008) Cancer epigenetics: modifications, screening, and therapy. Annu Rev Med 59: 267–280.
31. Geisler S. Coller J. (2013) RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14: 699–712.
32. Guo J. Su Y. Shin J. Shin J. Li H. Xie B. et al. (2013) Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci 17: 215–222.
33. Gusterson R. Jazrawi E. Adcock I. Latchman D. (2003) The transcriptional co-activators CREB-binding protein (CBP) and p 300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem 278: 6838–6847.
34. Haddad F. Bodell P. Qin A. Giger J. Baldwin K. (2003) Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J Biol Chem 278: 37132–37138.
35. Hergenreider E. Heydt S. Tréguer K. Boettger T. Horrevoets A. Zeiher A. et al. (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14: 249–256.
36. Hiltunen M. Turunen M. Häkkinen T. Rutanen J. Hedman M. Mäkinen K. et al. (2002) DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 7: 5–11.
37. Hofmann M. Schiekofer S. Kanitz M. Klevesath M. Joswig M. Lee V. et al. (1998) Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21: 1310–1316.
38. Horie T. Baba O. Kuwabara Y. Chujo Y. Watanabe S. Kinoshita M. et al. (2012) MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J Am Heart Assoc 1: e003376.
39. Huang R. Hu G. Lin B. Lin Z. Sun C. (2010) MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Invest Med 58: 961–967.
40. Ikeda S. Kong S. Lu J. Bisping E. Zhang H. Allen P. et al. (2007) Altered microRNA expression in human heart disease. Physiol Genomics 31: 367–373.
41. Iurlaro M. Ficz G. Oxley D. Raiber E. Bachman M. Booth M. et al. (2013) A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol 14: R119.
42. Jenuwein T. Allis C. (2001) Translating the histone code. Science 293: 1074–1080.
43. Ji H. Ehrlich L. Seita J. Murakami P. Doi A. Lindau P. et al. (2010) Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467: 338–342.
44. Kaneda R. Takada S. Yamashita Y. Choi Y. Nonaka-Sarukawa M. Soda M. et al. (2009) Genome-wide histone methylation profile for heart failure. Genes Cells 14: 69–77.
45. Kee H. Sohn I. Nam K. Park J. Qian Y. Yin Z. et al. (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113: 51–59.
46. Kelsey G. Feil R. (2013) New insights into establishment and maintenance of DNA methylation imprints in mammals. Philos Trans R Soc Lond B 368: 20110336.
47. Kim G. (2013) MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res J Lab Clin Med 161: 381–392.
48. Kim J. Kim J. Song K. Lee Y. Seo J. Jelinek J. et al. (2007) Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta 1772: 72–80.
49. Kim J. Yoon H. Ramírez C. Lee S. Hoe H. Fernández-Hernando C. et al. (2012) MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA 1 expression. Exp Neurol 235: 476–483.
50. Kook H. Lepore J. Gitler A. Lu M. Wing-Man Yung W. Mackay J. et al. (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112: 863–871.
51. Laribi S. Aouba A. Nikolaou M. Lassus J. Cohen-Solal A. Plaisance P. et al. (2012) Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail 14: 234–239.
52. Latronico M. Condorelli G. (2009) MicroRNAs and cardiac pathology. Nat Rev Cardiol 6: 419–429.
53. Laukkanen M. Mannermaa S. Hiltunen M. Aittomäki S. Airenne K. Jänne J. et al. (1999) Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 19: 2171–2178.
54. Leeper N. Raiesdana A. Kojima Y. Chun H. Azuma J. Maegdefessel L. et al. (2011) MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 226: 1035–1043.
55. Li B. Carey M. Workman J. (2007) The role of chromatin during transcription. Cell 128: 707–719.
56. Li Z. Hassan M. Jafferji M. Aqeilan R. Garzon R. Croce C. et al. (2009) Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 284: 15676–15684.
57. Ling C. Del Guerra S. Lupi R. Rönn T. Granhall C. Luthman H. et al. (2008) Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51: 615–622.
58. Lister R. Pelizzola M. Dowen R. Hawkins R. Hon G. Tonti-Filippini J. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315–322.
59. Liu F. Levin M. Petrenko N. Lu M. Wang T. Yuan L. et al. (2008) Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol 45: 715–723.
60. Lund G. Andersson L. Lauria M. Lindholm M. Fraga M. Villar-Garea A. et al. (2004) DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 279: 29147–29154.
61. Majumdar G. Johnson I. Kale S. Raghow R. (2008) Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin-18 and histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide. Mol Cell Biochem 312: 47–60.
62. Mao Y. Mohan R. Zhang S. Tang X. (2013) MicroRNAs as pharmacological targets in diabetes. Pharmacol Res 75: 37–47.
63. Marquart T. Allen R. Ory D. Baldán A. (2010) miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 107: 12228–12232.
64. Miao F. Gonzalo I. Lanting L. Natarajan R. (2004) In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091–18097.
65. Miao F. Wu X. Zhang L. Riggs A. Natarajan R. (2008) Histone methylation patterns are cell-type specific in human monocytes and lymphocytes and well maintained at core genes. J Immunol 180: 2264–2269.
66. Montgomery R. Davis C. Potthoff M. Haberland M. Fielitz J. Qi X. et al. (2007) Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21: 1790–1802.
67. Movassagh M. Choy M. Goddard M. Bennett M. Down T. Foo R. (2010) Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PloS ONE 5: e8564.
68. Movassagh M. Choy M. Knowles D. Cordeddu L. Haider S. Down T. et al. (2011) Distinct epigenomic features in end-stage failing human hearts. Circulation 124: 2411–2422.
69. Murray C. Lopez A. (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349: 1498–1504.
70. Mutskov V. Raaka B. Felsenfeld G. Gershengorn M. (2007) The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression. Stem Cells 25: 3223–3233.
71. Nabel E. Braunwald E. (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366: 54–63.
72. Najafi-Shoushtari S. Kristo F. Li Y. Shioda T. Cohen D. Gerszten R. et al. (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328: 1566–1569.
73. Natsume-Kitatani Y. Shiga M. Mamitsuka H. (2011) Genome-wide integration on transcription factors, histone acetylation and gene expression reveals genes co-regulated by histone modification patterns. PloS ONE 6: e22281.
74. Nazari-Jahantigh M. Wei Y. Noels H. Akhtar S. Zhou Z. Koenen R. et al. (2012) MicroRNA-155 promotes atherosclerosis by repressing Bcl 6 in macrophages. J Clin Invest 122: 4190–4202.
75. Ng H. Zhang Y. Hendrich B. Johnson C. Turner B. Erdjument-Bromage H. et al. (1999) MBD 2 is a transcriptional repressor belonging to the MeCP 1 histone deacetylase complex. Nat Genet 23: 58–61.
76. Nguyen A. Xiao B. Neppl R. Kallin E. Li J. Chen T. et al. (2011) DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev 25: 263–274.
77. Nichols M. Townsend N. Scarborough P. Rayner M. (2013) Cardiovascular disease in Europe: epidemiological update. Eur Heart J 34: 3028–3034.
78. Nikitina T. Shi X. Ghosh R. Horowitz-Scherer R. Hansen J. Woodcock C. (2007) Multiple modes of interaction between the methylated DNA binding protein MeCP 2 and chromatin. Mol Cell Biol 27: 864–877.
79. Oliveira-Carvalho V. Carvalho V. Bocchi E. (2013) The emerging role of miR-208a in the heart. DNA Cell Biol 32: 8–12.
80. Ørom U. Shiekhattar R. (2013) Long noncoding RNAs usher in a new era in the biology of enhancers. Cell 154: 1190–1193.
81. Pirola L. Balcerczyk A. Tothill R. Haviv I. Kaspi A. Lunke S. et al. (2011) Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 21: 1601–1615.
82. Polonsky K. (2012) The past 200 years in diabetes. N Engl J Med 367: 1332–1340.
83. Portela A. Esteller M. (2010) Epigenetic modifications and human disease. Nat Biotechnol 28: 1057–1068.
84. Post W. Goldschmidt-Clermont P. Wilhide C. Heldman A. Sussman M. Ouyang P. et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43: 985–991.
85. Puigserver P. Spiegelman B. (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78–90.
86. Qin B. Xiao B. Liang D. Xia J. Li Y. Yang H. (2011) MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem Biophys Res Commun 410: 127–133.
87. Rakyan V. Hildmann T. Novik K. Lewin J. Tost J. Cox A. et al. (2004) DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol 2: e405.
88. Ramirez C. Dávalos A. Goedeke L. Salerno A. Warrier N. Cirera-Salinas D. et al. (2011) MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31: 2707–2714.
89. Ramsahoye B. Biniszkiewicz D. Lyko F. Clark V. Bird A. Jaenisch R. (2000) Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A 97: 5237–5242.
90. Rayner K. Suárez Y. Dávalos A. Parathath S. Fitzgerald M. Tamehiro N. et al. (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328: 1570–1573.
91. Reddy M. Villeneuve L. Wang M. Lanting L. Natarajan R. (2008) Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res 103: 615–623.
92. Rivière G. Lienhard D. Andrieu T. Vieau D. Frey B. Frey F. (2011) Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 6: 478–489.
93. Rodenhiser D. Mann M. (2006) Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174: 341–348.
94. Shanmugam N. Reddy M. Guha M. Natarajan R. (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256–1264.
95. Smolarek I. Wyszko E. Barciszewska A. Nowak S. Gawronska I. Jablecka A. et al. (2010) Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 16: CR 149–155.
96. Stein A. Jones T. Herron T. Patel S. Day S. Noujaim S. et al. (2011) Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 121: 2641–2650.
97. Stenvinkel P. Karimi M. Johansson S. Axelsson J. Suliman M. Lindholm B. et al. (2007) Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med 261: 488–499.
98. Sun D. Zhang J. Xie J. Wei W. Chen M. Zhao X. (2012 a) MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA 1 and ARL7. FEBS Lett 586: 1472–1479.
99. Sun X. Icli B. Wara A. Belkin N. He S. Kobzik L. et al. (2012 b) MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest 122: 1973–1990.
100. Suzuki M. Bird A. (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465–476.
101. The Lancet (2013) Cardiovascular health for all. Lancet 382: 572.
102. Villeneuve L. Reddy M. Lanting L. Wang M. Meng L. Natarajan R. (2008) Epigenetic histone H 3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A 105: 9047–9052.
103. Wang D. Xia M. Yan X. Li D. Wang L. Xu Y. et al. (2012) Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res 111: 967–981.
104. Wilson A. (2008) Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 79: 1514–1519.
105. Yeh R. Sidney S. Chandra M. Sorel M. Selby J. Go A. (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362: 2155–2165.
106. Zernecke A. Bidzhekov K. Noels H. Shagdarsuren E. Gan L. Denecke B. et al. (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2: 81.
107. Zhang C. (2008) MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33: 139–147.
108. Zhang Q. Chen H. Wang L. Liu D. Hill J. Liu Z. (2011) The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest 121: 2447–2456.
109. Zhao Y. Ransom J. Li A. Vedantham V. von Drehle M. Muth A. et al. (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2. Cell 129: 303–317.
110. Zhu S. Goldschmidt-Clermont P. Dong C. (2005) Inactivation of monocarboxylate transporter MCT 3 by DNA methylation in atherosclerosis. Circulation 112: 1353–1361.